No history of arterial thrombotic events such as myocardial infarction (MI), unstable angina pectoris or any ischemic or hemorrhagic cerebrovascular accident (CVA) within past  months
. Subjects with any other concurrent, uncontrolled illness, including known psychiatric or substance abuse disorders which may interfere with the ability of the subject to cooperate and participate in the trial. Other examples of such conditions would include unstable angina, myocardial infarction (MI) or cerebrovascular accident (CVA) within  months of study entry.
Severe uncontrolled cardiac disease within  months of study entry, including but not limited to uncontrolled hypertension; unstable angina; myocardial infarction (MI) or cerebrovascular accident (CVA).
History of arterial thromboembolic event in past  months (including cerebrovascular accident [CVA], myocardial infarction [MI])
Myocardial infarction or cerebrovascular accident (CVA) within  months.
History of cerebrovascular accident (CVA), myocardial infarction or unstable angina within the previous  months before starting therapy.
Patients with a history of New York Heart Association class  or  heart failure, or history of myocardial infarction, unstable angina, or cerebrovascular accident (CVA) within  months of protocol registration
No cerebrovascular accident (CVA) within  months, no myocardial infarction (MI) within  months
Patients with a history of serious cardiac events defined as: New York Heart Association class  or  heart failure, or history of myocardial infarction, unstable angina or cerebrovascular accident (CVA) within  months of protocol registration
No cerebrovascular accident (CVA) within  months, no recent myocardial infarction (MI) within  months
Patients with clinically significant cardiovascular disease: History of CVA (cerebrovascular accident) within  months, myocardial infarction or unstable angina within  months, unstable angina pectoris
Patients with clinically significant cardiovascular disease: history of cerebrovascular accident (CVA) within  months, myocardial infarction or unstable angina within  months, or unstable angina pectoris
History of cerebrovascular accident (CVA), myocardial infarction or unstable angina within the previous  months before starting therapy
Patients with clinically significant cardiovascular disease: history of cerebrovascular accident (CVA) within  months, myocardial infarction or unstable angina within  months, or unstable angina pectoris
Patients with clinically significant cardiovascular disease: history of cerebrovascular accident (CVA) within  months; myocardial infarction or unstable angina within  months; unstable angina pectoris; New York Heart Association class > II
Patients with clinically significant cardiovascular disease: history of cerebrovascular accident (CVA) within  months, myocardial infarction or unstable angina within  months, unstable angina pectoris, New York Heart Association class CHF score II
Patients with history of acute myocardial infarction (MI) or cerebrovascular accident (CVA) within the last  months
Patients with evidence/history of cardiac disease including congestive heart failure, symptomatic arrhythmia not controlled by medication, unstable angina or cardiac disease, history of acute myocardial infarction (MI) or cerebrovascular accident (CVA) within the past six months
Patients with history of serious cardiac events defined as: \r\n* Patients with a history of New York Heart Association class  or  heart failure, or history of myocardial infarction, unstable angina or cerebrovascular accident (CVA) within  months of protocol registration \r\n* Patients who have history of PR prolongation (grade  or higher) or atrioventricular (AV) block
Myocardial infarction (MI); cerebrovascular accident (CVA); uncontrolled congestive heart failure (CHF); significant liver disease; or unstable angina within  months prior to enrollment
Myocardial infarction (MI); cerebrovascular accident (CVA); uncontrolled congestive heart failure (CHF); or unstable angina within  months prior to enrollment
Myocardial infarction (MI); cerebrovascular accident (CVA); uncontrolled congestive heart failure (CHF); significant liver disease; or unstable angina within  months prior to enrollment
Myocardial infarction (MI); cerebrovascular accident (CVA); uncontrolled congestive heart failure (CHF); or unstable angina within  months prior to enrollment
Had within  months prior to enrollment: myocardial infarction (MI), cerebrovascular accident (CVA), uncontrolled congestive heart failure (CHF), significant liver disease, unstable angina
Severe uncontrolled cardiac disease within  months of study entry, including but not limited to uncontrolled hypertension; unstable angina; myocardial infarction (MI) or cerebrovascular accident (CVA).
Severe or uncontrolled/unstable cardiac, pulmonary, hepatic or renal disease, including MI or CVA within  months prior to treatment.
Myocardial infarction (MI); cerebrovascular accident (CVA); uncontrolled congestive heart failure (CHF); significant liver disease; or unstable angina within  months prior to enrollment